Leptin, a hormone secreted by adipose tissue in proportion to body adiposity, is proposed to be involved in the central nervous regulation of food intake and body weight. In addition, evidence is emerging that leptin regulates neuroendocrine and metabolic functions as well, presumably via its action in the central nervous system (CNS). To investigate this regulatory effect of leptin, we infused 3.5 ug of human leptin directly into the third cerebral ventricle (i3vt) of lean male Long-Evans rats, 90 min before the onset of their dark phase. Before and after infusion, blood samples were withdrawn through indwelling catheters for assessment of hormonal (plasma corticosterone, insulin, leptin), autonomic (plasma norepinephrine, epinephrine), and metabolic (plasma glucose) parameters. 13vt leptin caused an increase in plasma corticosterone and plasma leptin levels relative to the control condition. The effects of i3vt leptin on corticosterone secretion became particularly apparent after the onset of the dark phase. The results of the present study indicate that i3vt leptin stimulates the hypothalamo-pituitary-adrenal (HPA) axis, particularly when rats normally encounter their largest meals. These results are consistent with the possibility that high circulating leptin levels may underlie the increased activity of the HPA axis that is generally characteristic of human obesity and most animal models of obesity. Diabetes 46:1911-1914, 1997 L eptin (OB protein), the protein encoded by the obese gene, has rapidly emerged as a key substance in the regulation of metabolism, adiposity, and food intake (1). It is secreted from white adipose tissue in direct proportion to the amount of stored triglycerides (2), and it interacts with specific receptors in hypothalamic areas important in the control of food intake and metabolism (3). Because its local administration into the brain results in reduced food intake (4-6), increased energy expenditure (7), and, if prolonged over days, decreased adiposity (8), leptin has been suggested to be an important negative feedback signal in the control of these parameters (9).
L eptin (OB protein), the protein encoded by the obese gene, has rapidly emerged as a key substance in the regulation of metabolism, adiposity, and food intake (1) . It is secreted from white adipose tissue in direct proportion to the amount of stored triglycerides (2) , and it interacts with specific receptors in hypothalamic areas important in the control of food intake and metabolism (3) . Because its local administration into the brain results in reduced food intake (4-6), increased energy expenditure (7) , and, if prolonged over days, decreased adiposity (8) , leptin has been suggested to be an important negative feedback signal in the control of these parameters (9) .
Consistent with this view, many species including primates and rodents secrete less leptin when they have been deprived of food (10) and have an increase in circulating leptin during states of positive energy balance (11) . Because peripheral administration of leptin to fasting mice reverses fastinginduced changes of the adrenal, thyroid, and gonadal axes (12, 13) , it is reasonable to hypothesize that changes of leptin levels related to the nutritional state may normally regulate neuroendocrine activity. Related to this, leptin may modulate autonomic outflow, since leptin administration in ob/ob mice stimulates norepinephrine turnover in brown adipose tissue (BAT) (14) .
There is a diurnal pattern of leptin secretion, with plasma leptin levels roughly correlating with diurnal patterns of food intake. This rhythm has been proposed to modulate circadian rhythmicity of the hypothalamo-pituitary-adrenal (HPA) axis (12) . To investigate a possible involvement of leptin in the regulation of neuroendocrine activity and autonomic outflow, we administered leptin (3.5 ug) into the third cerebral ventricle (i3vt) of Long-Evans rats at the end of their light cycle; i.e., when endogenous leptin levels are relatively low (12) . This dose of leptin has previously been found to reduce food intake (4), to stimulate c-fos activity in several hypothalamic and limbic areas (6), and following administration over several days, to decrease body weight as well (4) . Hormonal (plasma corticosterone, leptin, insulin), autonomic (plasma catecholamines), and metabolic (plasma glucose) indexes were assessed.
RESEARCH DESIGN AND METHODS
Animal preparation. Male Long-Evans rats (350-430 g) were individually housed on a 12:12-h light-dark cycle (at 20 ± 2°C). Pelleted standard laboratory diet and water were continuously available, except where noted. Under equithesin (3.3 ml/kg, i.p.) anesthesia, rats (n = 10) were provided with a silicon heart catheter (0.95 nun o.d.; 0.50 mm i.d.), and a 21-gauge stainless steel cannula (Plastics One, Roanoke, VA) aimed at the third cerebral ventricle (i3vt) (15, 6) . The silicon heart catheter allows frequent repeated blood sampling, and the i3vt cannula allows central drug administration in unanesthetized, undisturbed, and freely moving rats (15, 6) . A week later, brain cannula placements were confirmed by administration of 10 ng angiotensin in 1 ul of saline. Animals that did not drink 5 ml of water within 60 min were excluded from the experiment (n = 1). After 3 weeks of recovery, rats were habituated by twice-daily handling and being placed into the blood sampling chambers several times, where they had access only to water.
Experimental procedures. The experiment was conducted on 2 days, 1 week apart. On each experimental day, food was removed at 4 h before lights were shut off, and rats were taken from the colony to the experimental room. An hour later, each rat was connected to the blood sampling (PE 50, length 50 cm) tubing, and its obturator was replaced by an injector cannula that extended beyond the tip of the guide cannula by 1 mm. The injector cannula was connected to tubing (PE 20, length 100 cm) that was connected to a Hamilton syringe mounted on an infusion pump. The injector and its adjacent tubing contained 4 ul of infusate, which was isolated from the saline in the syringe by a small air bubble.
Two baseline blood samples of 0.5 ml each were taken before the infusion, at 120 and 90 min before lights were shut off. Directly after the second baseline sample, rats received an i3vt infusion (3.5 ul during 1 min) of either synthetic cerebrospinal fluid (sCSF) or human leptin (1) in sCSF (1 ug/ul). Each rat received each infusate in random order. Thereafter, blood samples (0.5 ml each) were taken at 75,45, and 15 min before lights were shut off, and in the dark phase, every 15 min after the hour for 4 h. After each blood sample was taken, a transfusion of a similar volume of heparinized donor blood (taken from undisturbed overnight fooddeprived donor rats) was administered intravenously to the animals to avoid reduction of blood volume. After the final blood sample was taken, the rats were transported back to the colony room, and food intake was assessed over the subsequent 8 h. Chemical analyses. Blood samples were immediately transferred to chilled (0°C) centrifuge tubes containing heparin (10 ul, 1,000 U) and EDTA. Whenever blood for analysis of leptin concentrations was taken, this blood was transferred to separate centrifuge tubes that contained only heparin. The samples were immediately centrifuged (15 min, 4,300 rpm at 4°C). Plasma for measurement of the concentration of catecholamines (100 ul) and leptin (40 ul) was immediately stored at -80°C. The remaining plasma was stored at -20°C for subsequent measurement of the concentration of insulin (50 ul), corticosterone (30 pi), and glucose (30 ul). Determination of catecholamine concentration was performed as previously described (16) . Glucose concentration was enzymatically analyzed. Insulin, leptin, and corticosterone levels were determined with sensitive radioimmunoassays. Although the sensitivity of the mouse-leptin antibody (Linco) is relatively low (35%) for rat leptin, this antibody was chosen because it has no cross-reactivity with human leptin (R. Gingrich, personal communication, 1996). Data analyses. All data are expressed as means ± SE. A two-way analysis of variance (ANOVA) with repeated measures was applied to assess differences between the effects of leptin and sCSF on concentrations of plasma components and food intake. When significant differences were found, post hoc analyses were conducted using Student's t test. In all cases, P < 0.05 (two-tailed) indicated statistical significance.
RESULTS
The effects of administration of i3vt leptin (3.5 pg in 3.5 ul of sCSF) and i3vt sCSF on concentrations of plasma corticosterone, leptin, and insulin are depicted in Fig. 1 . ANOVA revealed significant drug effects and interaction effects (drug X time) on plasma corticosterone [drug: F(l,80) = 36.49, P < 0.0001, time X drug: F(9,80) = 2.68, P < 0.009] and plasma leptin [drug: F(l,40) = 17.26, P < 0.0002, time X drug: F(4,40) = 3.41, P < 0.02]. ANOVA revealed an effect of time on plasma insulin [F(9.80) = 2.29, P < 0.02], whereas a drug effect neared significance [F(l,80) = 3.88, P = 0.052]. Post hoc analysis revealed significantly higher plasma corticosterone levels following leptin than following sCSF at 7:15 P.M. (75 min after lights were shut off), 8:15 P.M., and 9:15 P.M. Plasma leptin levels were significantly higher following i3vt leptin than sCSF at 8:15 P. M. and 10:15 P.M. Figure 2 depicts the effects of leptin on plasma norepinephrine and glucose. ANOVA revealed only a time effect on plasma glucose [F(9,80) = 2.18, P < 0.03]. There was no significant effect of i3vt leptin on the concentration of plasma norepinephrine. There was also no effect of i3vt leptin on plasma epinephrine levels (data not shown). 
DISCUSSION
We previously reported that i3vt infusion of leptin reduces food intake and body weight in rats (4), without producing adverse side effects (5) . We now report that this dose of leptin increases plasma corticosterone relative to the control condition, suggesting that i3vt leptin activates the HPA axis. Importantly, the increase of plasma corticosterone levels following leptin administration was not apparent until after the onset of the dark phase, suggesting that leptin's effect on the HPA axis may rely on one or more neurochemical substrate^) linked to circadian rhythmicity. Alternatively, it cannot be excluded that the HPA axis is activated by i3vt leptin in a delayed fashion. A stimulatory effect of leptin on the HPA axis is consistent with other findings. Schwartz et al. (3) reported that i3vt leptin increases the message for corticotropin-releasing hormone (CRH) in hypothalamic neurons of rats deprived of food for 40 h. We have reported that the same dose of leptin used in the present study stimulates c/os-synthesis (a marker of neuronal activity) in cell bodies in the parvocellular division of the paraventricular hypothalamic nucleus (PVN) (6), a region containing abundant cell bodies that synthesize CRH (17) , and CRH is a major stimulant of corticosterone secretion. Indirect evidence for a link between leptin and hypothalamic CRH stems from the observation that increases in the message of PVN CRH and circulating leptin coexist during a positive energy balance, while underfeeding reduces both circulating leptin and hypothalamic CRH synthesis (10, 18) . Finally, the stimulatory effects of i3vt leptin on thermogenesis and oxygen consumption (7) could be explained via activation of hypothalamic CRH projection to the preganglionic neurons of the sympathetic nervous system (19,17). These preganglionics have direct connections with BAT. Such effects may also be reflected by the acute increase of the plasma norepinephrine level (Fig. 2 ) following i3vt leptin in the present study. In contrast to the elevation of the plasma corticosterone level following i3vt leptin in the present study, Ahima et al. (12) reported that intraperitoneal injections of leptin to mice fasted for 48 h partly reversed the fasting-induced elevation of plasma corticosterone and ACTH levels. While this apparent discrepancy may be due to species differences, another possibility is that leptin has both stimulatory and inhibitory effects on activity of the HPA axis. This would occur if the mechanism underlying the increased activity of the HPA axis during starvation differs from that which causes activation of the HPA axis at the circadian peak. For example, increased hypothalamic neuropeptide Y (NPY) transmission may be the primary drive for activation of the HPA axis during starvation (20) , whereas CRH is important for the increase in the HPA axis at the onset of the dark phase (21) . Since leptin inhibits and activates hypothalamic NPY and CRH (3), respectively, it may be speculated that these opposite effects of leptin are causal to the differential regulation of leptin on fasting-and circadian-induced increases in HPA axis activity.
Both insulin and cortisol (22) have been reported to increase leptin synthesis and secretion, a finding which could explain the increase of plasma leptin following i3vt leptin administration in the present study. The increased plasma leptin level cannot be the result of leakage of administered leptin from brain to plasma since the radioimmunoassay for mouse leptin used in the present study, while relatively sensitive to rat leptin, has no cross-reactivity with the human leptin administered (R. Gingrich, personal communication, 1996) . It remains possible that human leptin did enter the plasma in the present experiment, and that it indirectly caused an increase of plasma rat leptin, for example, by preferentially binding to leptin binding protein and displacing endogenous leptin (23) . It is also possible that a sudden increase of leptin in the ventricular fluid causes the secretion of peripheral leptin, analogously to the vagally mediated secretion of pancreatic insulin that occurs when ventricular insulin is elevated (24) .
In summary, the present results demonstrate that i3vt leptin administration at the end of the light phase (in a dose that reduces food intake) leads to an increased activation of the HPA axis (as reflected by increased plasma corticosterone) and is associated with increased plasma leptin. These results are consistent with the possibility that high circulating leptin may underlie the increased activity of the HPA axis that is generally characteristic of human obesity and most animal models of obesity. The results further indicate that this effect is especially robust at the time when animals normally eat their largest daily meal. Further research should focus on the circadian and energetic state-related aspects (both physiological and behavioral) that underlie the sensitivity and direction to modulate the activity of the HPA axis.
